Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01750580
Recruitment Status : Completed
First Posted : December 17, 2012
Last Update Posted : July 22, 2015
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2015
  Study Completion Date : April 2015